Effects of storage, RNA extraction, genechip type, and donor sex on gene expression profiling of human whole blood

Clinical Chemistry

Volumn 53, Issue 6, 2007, Pages 1038-1045

  Sung, Jae Kim ^a,b   Dix, David J ^a,d,e   Thompson, Kary E ^a,f   Murrell, Rachel N ^a,c,g   Schmid, Judith E ^a   Gallagher, Jane E ^a   Rockett, John C ^a,h  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c NORTH CAROLINA STATE UNIVERSITY   (United States)

^d U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^e National Center for Computational Toxicology   (United States)

^f BRISTOL MYERS SQUIBB   (United States)

^g EAST CAROLINA UNIVERSITY   (United States)

^h ROSETTA INPHARMATICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RNA;

ADULT; ARTICLE; BLOOD ANALYSIS; CHEMICAL PARAMETERS; DONOR; FEMALE; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; GENETIC VARIABILITY; HUMAN; HUMAN EXPERIMENT; MALE; MULTIVARIATE ANALYSIS; NORMAL HUMAN; RNA EXTRACTION; RNA ISOLATION; SEX DIFFERENCE; STORAGE; TOTAL QUALITY MANAGEMENT;

ADULT; CLUSTER ANALYSIS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PRINCIPAL COMPONENT ANALYSIS; RNA; SEX FACTORS;

EID: 34249914273     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2006.078436     Document Type: Article

References (21)

1. Rockett JC, Burczynski ME, Fornace AJ, Harrmann PC, Krawetz SA, Dix DJ. Surrogate tissue analysis: monitoring toxicant exposure and health status of inaccessible tissues through the analysis of accessible tissues and cells. Toxicol Appl Pharmacol 2004;194: 189-99.
2. Tang Y, Lu A, Aronow BJ, Sharp FR. Blood genomic responses differ after stroke, seizures, hypoglycemia, and hypoxia: blood genomic fingerprints of disease. Ann Neurol 2001;50:699-707.
3. Rockett JC, Kavlock RJ, Lambright C, Parks LG, Schmid JE, Wilson VS, et al. DNA arrays to monitor gene expression in rat blood and uterus following 17-β-estradiol exposure: biomonitoring environmental effects using surrogate tissues. Toxicol Sci 2002;69:49-59.
4. Twine NC, Stover JA, Marshall B, Dukert G, Hidalgo M, Stadlar W, et al. Disease-associated expression profiles in peripheral blood mononuclear cells from patients with advanced renal cell carcinoma. Cancer Res 2003;63:6069-75.
5. Whitney AR, Diahn M, Popper SJ, Alizadeh AA, Boldrick JC, Ralman DA, et al. Individuality and variation in gene expression patterns in human blood. Proc Natl Acad Sci U S A 2003;100:1896-901.
6. Radich JP, Mao M, Stepaniants S, Blary M, Castla J, Ward T, et al. Individual-specific variation of gene expression in peripheral blood leukocytes. Genomics 2004;83:980-8.
7. Eady JJ, Wortley GM, Wormstona YM, Hughes JC, Astlay SB, Foxall RJ, et al. Variation in gene expression profiles of peripheral blood mononuclear cells from healthy volunteers. Physiol Genomics 2005;22:402-11.
8. Rainan L, Oelmuallar U, Jurgensen S, Wyrich R, Ballas C, Schrem J, et a. Stabilization of mRNA expression in whole blood samples. Clin Chem 2002;48:1883-90.
9. Tannar MA, Bark LS, Felten DL, Bildy AD, Bit SL, Ruff DW. Substantial changes in gene expression level due to the storage temperature and storage duration of human whole blood. Clin Lab Haematol 2002;24:337-41.
10. Thach DC, Lin B, Walter E, Kruzelock R, Rowley RK, Tibbetts C, et al. Assessment of two methods for handling blood in collection tubes with RNA stabilizing agent for surveillance of gene expression profiles with high density microarrays. J Immunol Methods 2003;283:269-79.
11. Wang J, Robinson JF, Khan HM, Carter DE, McKinney J, Miskle BA, et al. Optimizing RNA extraction yield from whole blood for microarray gene expression analysis. Clin Biochem 2004;37: 741-4.
12. Debey S, Schoenbeck U, Hellmich M, Gethof BS, Pillal R, Zander T, et al. Comparison of different isolation techniques prior gene expression profiling of blood derived cells: impact on physiological responses, on overall expression and the role of different cell types. Pharmacogenomics J 2004;4:193-207.
13. Vu NT, Zhu H, Owuor ED, Huggins ME, White VL, Charturvedi AK, et al. Isolation of RNA from peripheral blood cells: a validation study for molecular diagnostics by microarray and kinetic RT-PCR assays: application in aerospace medicine. Office of Aerospace Medicine, US Department of Transportation, Federal Aviation Administration Report No. DOT/FAA/AM-04/1. 2004.
14. Baugh LR, Hill AA, Brown EL, Hunter CP. Quantitative analysis of mRNA amplification by in vitro transcription. Nucleic Acids Res 2001;29:E29.
15. Gold D, Coombes K, Medhane D, Ramaswamy A, Ju Z, Strong L, et al. A comparative analysis of date generated using two different target preparation methods for hybridization to high-density oligonucleotide microarrays. BMC Genomics 2004;5:2.
16. Li L, Roden J, Shapiro BE, Wold BJ, Bhatia S, Forman SJ, et al. Reproducibility, fidelity, and discriminant validity of mRNA amplification for microarray analysis from primary hematopoietic cells. J Mol Diagn 2005;7:48-56.
17. Mueller O, Lightfoot S, Schroeder A. RNA integrity number (RIN): standardization of RNA quality control. Agilent Technologies Application Note, 2004. http://www.chem.agilent.com/temp/radA423C/00047692.pdf (accessed December 7, 2005).
18. Pahl A, Brune K. Gene expression changes in blood after phlebotomy: Implications for gene expression profiling. Blood 2002;100: 1094-5.
19. Affymetrix. Globin reduction protocol: a method for processing for whole blood RNA samples for improved array results. http://www.affymetrix.com/support/ technical/technotes/blood2_technote.pdf (accessed February 2, 2006).
20. Dumur CI, Garrett CT, Archer KJ, Nasim S, Wilkinson DS, Ferreira-Gonzalez A. Evaluation of a linear amplification method for small samples used on high-density oligonucleotide microarray analysis. Anal Biochem 2004;331:314-21.
21. Affymetrix. What 3′/5′ ratio for control genes, for example GAPDH and Actin, should I anticipate to obtain on GeneChip probe arrays? http://www.affymetrix.com/support/help/faqs/ge_assays/faq_17.jsp (accessed February 2, 2006).